Cargando…

Nivolumab-induced cholangitis in patients with non-small cell lung cancer: Case series and a review of literature

Immune checkpoint inhibitors (ICIs), including nivolumab, have exhibited substantial benefits in the treatment of several types of cancers. However, treatment with ICIs is often accompanied by immune-related adverse events (irAEs), and a clear understanding of the precise indications and management...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izumi, Hiroki, Kodani, Masahiro, Kurai, Jun, Takeda, Kenichi, Okazaki, Ryota, Yamane, Kohei, Teruya, Yasuhiko, Yamamoto, Akihiro, Sueda, Yuriko, Yanai, Masaaki, Tanaka, Natsumi, Sakamoto, Tomohiro, Yamaguchi, Kosuke, Makino, Haruhiko, Igishi, Tadashi, Yamasaki, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781813/ https://www.ncbi.nlm.nih.gov/pubmed/31616560 http://dx.doi.org/10.3892/mco.2019.1923

Ejemplares similares

Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase-inhibitory fluoropyrimidine in EGFR-mutated lung adenocarcinoma: Retrospective and in vitro studies
por: IZUMI, HIROKI, et al.
Publicado: (2015)

A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer
por: SAKAMOTO, TOMOHIRO, et al.
Publicado: (2015)

Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastases
por: Izumi, Hiroki, et al.
Publicado: (2017)

Pembrolizumab-induced aseptic meningitis in a patient with non-small cell lung cancer: A case report and literature review of aseptic meningitis as an immune-related adverse event
por: Inui, Genki, et al.
Publicado: (2022)

A novel SLC34A2 mutation in a patient with pulmonary alveolar microlithiasis
por: Izumi, Hiroki, et al.
Publicado: (2017)

Granulomatosis with polyangiitis diagnosed during the treatment of otitis media with prednisolone in a patient with anti-neutrophil cytoplasmic antibody-associated vasculitis: A case report
por: Tokuyasu, Hirokazu, et al.
Publicado: (2022)

A case of lung abscess successfully treated by transbronchial drainage using a guide sheath
por: Izumi, Hiroki, et al.
Publicado: (2017)

Splenic Infarction in Acute Cytomegalovirus and Human Parvovirus Concomitant Infection
por: Harada, Tomoya, et al.
Publicado: (2018)

An onion farmer with a case of hypersensitivity pneumonitis caused by Aspergillus niger
por: Sakamoto, Tomohiro, et al.
Publicado: (2017)

Causes of death in patients with asthma and asthma–chronic obstructive pulmonary disease overlap syndrome
por: Harada, Tomoya, et al.
Publicado: (2015)

Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma
por: KURAI, JUN, et al.
Publicado: (2012)

Nivolumab-related Sclerosing Cholangitis in Gastric Cancer
por: Motoo, Yoshiharu
Publicado: (2019)

A new rapid method for detecting epidermal growth factor receptor mutations in non-small cell lung cancer
por: TAKATA, MIYAKO, et al.
Publicado: (2015)

Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
por: Joob, Beuy, et al.
Publicado: (2022)

Association of Sand Dust Particles with Pulmonary Function and Respiratory Symptoms in Adult Patients with Asthma in Western Japan Using Light Detection and Ranging: A Panel Study
por: Watanabe, Masanari, et al.
Publicado: (2015)

COPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospital
por: Yamasaki, Akira, et al.
Publicado: (2010)

The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary disease
por: Takeda, Kenichi, et al.
Publicado: (2013)

Successful Treatment of Nivolumab-related Cholangitis with Prednisolone: A Case Report and Review of the Literature
por: Sawada, Koji, et al.
Publicado: (2019)

Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up
por: McClure, Tess, et al.
Publicado: (2020)

Nivolumab-Induced Severe Akathisia in an Advanced Lung Cancer Patient
por: Abe, Jiro, et al.
Publicado: (2016)

Comparison of pathological findings and accumulation of fluorin-18 fluorodeoxyglucose on positron emission tomography/computed tomography: A case of relapsing polychondritis
por: Tokuyasu, Hirokazu, et al.
Publicado: (2023)

Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report
por: Agrawal, Rohit, et al.
Publicado: (2022)

Concurrence of nivolumab‐induced interstitial lung disease and cancer invasion
por: Kanai, Osamu, et al.
Publicado: (2017)

Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab
por: Uchida, Naohiro, et al.
Publicado: (2017)

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients
por: Osa, Akio, et al.
Publicado: (2018)

A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy
por: Hirasawa, Yuya, et al.
Publicado: (2021)

Concurrent Nivolumab-Induced Gastritis and Cholangitis Accompanied by Biliary Tract Hemorrhage in a Patient With Stage IV Lung Adenocarcinoma
por: Tsukaguchi, Akihiro, et al.
Publicado: (2023)

Small cell lung cancer transformation during immunotherapy with nivolumab: A case report
por: Imakita, Takuma, et al.
Publicado: (2017)

Clinical Characteristics of ICI-Related Pancreatitis and Cholangitis Including Radiographic and Endoscopic Findings
por: Nakano, Ryota, et al.
Publicado: (2022)

Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis
por: Fujinaga, Yukihisa, et al.
Publicado: (2022)

Sustained Eosinophilic Cholangitis Due to a Mite Allergy Mimicking Sclerosing Cholangitis
por: Motoya, Masayo, et al.
Publicado: (2022)

Nivolumab-induced interstitial lung disease in a patient with gastric cancer
por: Kimura, Akie, et al.
Publicado: (2019)

Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab
por: Kanda, Shinichiro, et al.
Publicado: (2023)

Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis
por: Fujinaga, Yukihisa, et al.
Publicado: (2021)

Severe Gastritis after Administration of Nivolumab and Ipilimumab
por: Nishimura, Yoshito, et al.
Publicado: (2018)

Acute Cerebellar Ataxia Induced by Nivolumab
por: Kawamura, Reina, et al.
Publicado: (2017)

Pseudoprogression during induction treatment with nivolumab plus ipilimumab combined with chemotherapy for metastatic lung adenocarcinoma: A case report
por: Kunimatsu, Yusuke, et al.
Publicado: (2023)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Yoshimura, Katsuhiro, et al.
Publicado: (2021)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Neutrophils and Asthma
por: Yamasaki, Akira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qmt6mho8uj6cfkotihjr67a34s